We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

67 hedge funds and large institutions have $42.1M invested in Zynerba Pharmaceuticals, Inc in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more capital invested

Capital invested by funds: $21.6M → $42.1M (+$20.5M)

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

73% more call options, than puts

Call options by funds: $4.74M | Put options by funds: $2.74M

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

16% more funds holding

Funds holding: 58 → 67 (+9)

Holders
67
Holders Change
+9
Holders Change %
+15.52%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
20
Reduced
12
Closed
10
Calls
$4.74M
Puts
$2.74M
Net Calls
+$2M
Net Calls Change
+$1.66M

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$4.2M
2
IEFM
IQ EQ Fund Management
Ireland
+$2.94M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.22M
4
PCM
Penserra Capital Management
California
+$1.03M
5
BlackRock
BlackRock
New York
+$857K

Top Sellers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$1.61M
2
Renaissance Technologies
Renaissance Technologies
New York
-$475K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$426K
4
LSA
Leonteq Securities AG
Switzerland
-$322K
5
SC
Sculptor Capital
New York
-$271K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$142K – – –
Jane Street
27
Jane Street
New York
$142K +$138K +30,431 New
Wells Fargo
28
Wells Fargo
California
$134K +$120K +26,458 +1,071%
BWP
29
Bernardo Wealth Planning
Pennsylvania
$126K – – –
LPL Financial
30
LPL Financial
California
$109K +$47K +10,371 +79%
Millennium Management
31
Millennium Management
New York
$104K +$101K +22,380 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$100K -$8.62K -1,902 -8%
AG
33
Algert Global
California
$97K – – –
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$84K – – –
ECM
35
ExodusPoint Capital Management
New York
$84K +$81.8K +18,047 New
KWMG
36
King Wealth Management Group
Florida
$74K – – –
CSS
37
Cubist Systematic Strategies
Connecticut
$67K +$65.3K +14,401 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$66K +$62.2K +13,729 +2,746%
AAA
39
Affinity Asset Advisors
New York
$62K – – –
Commonwealth Equity Services
40
Commonwealth Equity Services
Massachusetts
$59K -$3.11K -687 -5%
LSA
41
Leonteq Securities AG
Switzerland
$55.1K -$322K -71,079 -86%
Osaic Holdings
42
Osaic Holdings
Arizona
$55K +$2.67K +590 +5%
State Street
43
State Street
Massachusetts
$54K +$52.6K +11,600 New
Capstone Investment Advisors
44
Capstone Investment Advisors
New York
$50K +$48.3K +10,647 New
UBS Group
45
UBS Group
Switzerland
$21K -$12.4K -2,726 -38%
CG
46
Cutler Group
California
$8K -$9.25K -2,040 -53%
CH
47
Canton Hathaway
Rhode Island
$5K +$4.53K +1,000 New
FFA
48
Freedman Financial Associates
Massachusetts
$4K – – –
IAIM
49
International Assets Investment Management
Florida
$3K +$907 +200 +32%
Bank of America
50
Bank of America
North Carolina
$3K +$1.95K +430 +426%
1
2
3

ZYNE Hedge Fund Activity: Q1 2021 in Review

67 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q1 2021, worth a combined $42.1M — up 95% from $21.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ZYNE positions and 10 closed out — a net gain of 9 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $4.2M. The largest seller was Mirae Asset Global Investments, cutting an estimated $1.61M.

  • 67 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q1 2021, up from 58 in Q4 2020.
  • Funds reported $42.1M of Zynerba Pharmaceuticals, Inc stock for Q1 2021, up 95% quarter-over-quarter.
  • 19 funds opened new Zynerba Pharmaceuticals, Inc positions in Q1 2021 and 10 closed out, a net change of +9 holders.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q1 2021 was AdvisorShares Investments, an estimated $4.2M added.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q1 2021 was Mirae Asset Global Investments, an estimated $1.61M sold.

Based on aggregated 13F filings for Q1 2021.